TrialScientific reports2020

Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes.

Jens Aberle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.